Cholinesterase inhibitors for the treatment of Alzheimer's disease: Synthesis, biological analysis and molecular docking study of sulphur containing heterocyclic analogues

被引:4
|
作者
Ullah, Hayat [1 ]
Rahim, Fazal [2 ]
Uddin, Imad [3 ]
Taha, Muhammad [4 ]
Khan, Misbah Ullah [5 ]
Khan, Fahad [2 ]
Khan, Shoaib [6 ]
Hussain, Rafaqat [2 ]
Hussain, Amjad [1 ]
Iqbal, Naveed [7 ]
Gul, Farzana [8 ]
机构
[1] Univ Okara, Dept Chem, Okara 56130, Pakistan
[2] Hazara Univ, Dept Chem, Mansehra 21300, Khyber Pakhtunk, Pakistan
[3] Univ Haripur, Dept Chem, Haripur 22620, Khyber Pakhtunk, Pakistan
[4] Imam Abdulrahman Bin Faisal Univ, Inst Res & Med Consultat IRMC, Dept Clin Pharm, POB 1982, Dammam 31441, Saudi Arabia
[5] Univ Okara, Ctr Nanosci, Okara 56130, Pakistan
[6] Abbottabad Univ Sci & Technol AUST, Dept Chem, Abbottabad, Pakistan
[7] Univ Poonch, Dept Chem, Rawalakot, Ajk, Pakistan
[8] Hazara Univ, Dept Biochem, Mansehra 21300, Khyber Pakhtunk, Pakistan
来源
CHEMICAL DATA COLLECTIONS | 2024年 / 51卷
关键词
Synthesis; Thiophene; Sulfonamide; Acetylcholinesterase; Butyrylcholinesterase; GLUTATHIONE-S-TRANSFERASE; CARBONIC-ANHYDRASE; ACETYLCHOLINE ESTERASE; ALPHA-GLUCOSIDASE; DERIVATIVES; BUTYRYLCHOLINESTERASE; ANTIOXIDANT; LACTOPEROXIDASE; THIAZOLE; BASES;
D O I
10.1016/j.cdc.2024.101132
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In synthetic medicinal chemistry thiophene and their analogues play a vital role due to the wide range of pharmacological properties. In current studies, we have synthesized a new class of thiophene-bearing sulfonamide analogues (1-11) as cholinesterase inhibitors. These newly synthesized upon esterification, hydrazide formation and finally through sulfonamide mode of synthesis and were characterized through 1H, 13C NMR and HREI-MS spectroscopic techniques. Synthesized analogues showed an excellent to moderate cholinesterase inhibitory potential. Analogues 10, 7, 9 and 11 showed an excellent potency against cholinesterase inhibition as compared to standard Donepezil. The binding interactions of the most potent analogues were confirmed through molecular docking studies. All Compounds were verified for cytotoxicity against 3T3 mouse fibroblast cell line and detected non-toxic.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Synthesis, biological evaluation, and molecular docking study of novel 1,2,4-substituted triazoles as inhibitors of alzheimer's disease
    Ali, Saima
    Siddiqui, Sabahat Zahra
    Khan, Khalid Mohammed
    Abbasi, Muhammad Athar
    Aziz-ur-Rehman
    Saad, Syed Muhammad
    Shah, Syed Adnan Ali
    Saleem, Rahman Shah Zaib
    Ashraf, Muhammad
    JOURNAL OF THE IRANIAN CHEMICAL SOCIETY, 2022, 19 (11) : 4491 - 4502
  • [32] Pharmacoeconomics of Alzheimer's disease (AD) treatment with cholinesterase inhibitors
    Versijpt, Jan
    ACTA NEUROLOGICA BELGICA, 2012, 112 (02) : 141 - 145
  • [33] Pharmacoeconomics of Alzheimer’s disease (AD) treatment with cholinesterase inhibitors
    Jan Versijpt
    Acta Neurologica Belgica, 2012, 112 : 141 - 145
  • [34] Defining optimal treatment with cholinesterase inhibitors in Alzheimer's disease
    Small, Gary
    Bullock, Roger
    ALZHEIMERS & DEMENTIA, 2011, 7 (02) : 177 - 184
  • [35] Cholinesterase inhibitors for the treatment of Alzheimer's disease: Getting on and staying on
    Grossberg, GT
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2003, 64 (04): : 216 - 235
  • [36] Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias
    Masterman, D
    CLINICS IN GERIATRIC MEDICINE, 2004, 20 (01) : 59 - +
  • [37] Coumarin analogues as potential inhibitors of acetylcholinesterase: Synthesis, molecular docking, and biological studies
    Singla, Shaffali
    Piplani, Poonam
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [38] Design, synthesis, biological evaluation and molecular docking of cyclic biguanidine compounds as cholinesterase inhibitors
    Gungor, Ozge
    Kose, Muhammet
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (20): : 10885 - 10899
  • [39] Arylaminopropanone Derivatives as Potential Cholinesterase Inhibitors: Synthesis, Docking Study and Biological Evaluation
    Hudcova, Anna
    Kroutil, Ales
    Kubinova, Renata
    Garro, Adriana D.
    Gutierrez, Lucas J.
    Enriz, Daniel
    Oravec, Michal
    Csollei, Jozef
    MOLECULES, 2020, 25 (07):
  • [40] Treatment of Alzheimer's disease with cholinesterase inhibitors in Germany: A cost-effectiveness study
    Faltraco, F
    Happich, M
    Reisig, V
    Teipel, SJ
    Moeller, HJ
    Hampel, H
    NEUROBIOLOGY OF AGING, 2004, 25 : S336 - S336